Resurgence of Acanthamoeba keratitis in Auckland, New Zealand: A 7-year review of presentation and outcomes

Clinical and Experimental Ophthalmology

Volumn 38, Issue 1, 2010, Pages 15-20

  Patel, Dipika V ^a   Rayner, Sandra ^a   McGhee, Charles N J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Acanthamoeba; Cornea; Infection; Keratitis

Indexed keywords

CHLORHEXIDINE; CORTICOSTEROID; POLY(HEXAMETHYLENEBIGUANIDE); PROPAMIDINE ISETHIONATE;

ACANTHAMOEBA KERATITIS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONFOCAL MICROSCOPY; CONTACT LENS; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY DIAGNOSIS; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; HUMAN; KERATOPLASTY; MALE; MICROBIOLOGICAL EXAMINATION; NEW ZEALAND; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR; VISUAL ACUITY;

ACANTHAMOEBA KERATITIS; ADULT; ANIMALS; ANTIPROTOZOAL AGENTS; CONTACT LENSES; CORNEA; FEMALE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEW ZEALAND; OPHTHALMOLOGIC SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; RISK FACTORS; VISUAL ACUITY; YOUNG ADULT;

EID: 77950942442     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2009.02182.x     Document Type: Article

References (28)

1. Naginton J, Watson PG, Playfair TJ, McGill J, Jones BR, Steele AD. Amoebic infection of the eye. Lancet 1974, 2:1537-40.
2. Seal DV. Acanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment. Eye 2003, 17:893-905.
3. Illingworth CD, Cook SD. Acanthamoeba keratitis. Surv Ophthalmol 1998, 42:493-508.
4. Schaumberg DA, Snow KK, Dana MR. The epidemic of Acanthamoeba keratitis: where do we stand? Cornea 1998, 17:3-10. see comment
5. Ibrahim YW, Boase DL, Cree IA. Factors affecting the epidemiology of Acanthamoeba keratitis. Ophthalmic Epidemiol 2007, 14:53-60.
6. Radford CF, Lehmann OJ, Dart JK. Acanthamoeba keratitis: multicentre survey in England 1992-6. National Acanthamoeba Keratitis Study Group. Br J Ophthalmol 1998, 82:1387-92.
7. Patel A, Hammersmith K. Contact lens-related microbial keratitis: recent outbreaks. Curr Opin Ophthalmol 2008, 19:302-6.
8. Joslin CE, Tu EY, Shoff ME. The association of contact lens solution use and Acanthamoeba keratitis. Am J Ophthalmol 2007, 144:169-80.
9. Murdoch D, Gray TB, Cursons R, Parr D. Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide. Aust N Z J Ophthalmol 1998, 26:231-6.
10. Gebauer A, McGhee CN, Crawford GJ. Severe microbial keratitis in temperate and tropical Western Australia. Eye 1996, 10:575-80.
11. Dart JK. Disease and risks associated with contact lenses. Br J Ophthalmol 1993, 77:49-53.
12. Lam DS, Houang E, Fan DS. Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. Eye 2002, 16:608-18.
13. Seal DV, Kirkness CM, Bennett HG, Peterson M. Population-based cohort study of microbial keratitis in Scotland: incidence and features. Cont Lens Anterior Eye 1999, 22:49-57.
14. Wong T, Ormonde S, Gamble G, McGhee CN. Severe infective keratitis leading to hospital admission in New Zealand. Br J Ophthalmol 2003, 87:1103-8.
15. Joslin CE, Tu EY, McMahon TT, Passaro DJ, Stayner LT, Sugar J. Epidemiological characteristics of a Chicago-area Acanthamoeba keratitis outbreak. Am J Ophthalmol 2006, 142:212-7.
16. Ku JY, Chan FM, Beckingsale P. Acanthamoeba keratitis cluster: An increase in Acanthamoeba keratitis in Australia. Clin Experimental Ophthalmol 2009, 37(2):181-90.
17. Thebpatiphat N, Hammersmith KM, Rocha FN. Acanthamoeba keratitis: a parasite on the rise. Cornea 2007, 26:701-6.
18. Claerhout I, Goegebuer A, Van Den Broecke C, Kestelyn P. Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefes Arch Clin Exp Ophthalmol 2004, 242:648-53.
19. Tay-Kearney ML, McGhee CN, Crawford GJ, Trown K. Acanthamoeba keratitis. A masquerade of presentation in six cases. Aust N Z J Ophthalmol 1993, 21:237-45.
20. Duguid IG, Dart JK, Morlet N. Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology 1997, 104:1587-92.
21. Perry HD, Donnenfeld ED, Foulks GN, Moadel K, Kanellopoulos AJ. Decreased corneal sensation as an initial feature of Acanthamoeba keratitis. Ophthalmology 1995, 102:1565-8.
22. Sun X, Zhang Y, Li R. Acanthamoeba keratitis: clinical characteristics and management. Ophthalmology 2006, 113:412-6.
23. Patel DV, McGhee CN. Acanthamoeba keratitis: A comprehensive photographic reference of common and uncommon signs [Review]. Clin Experiment Ophthalmol 2009, 37(2):232-8.
24. Illingworth CD, Cook SD, Karabatsas CH, Easty DL. Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol 1995, 79:1078-82.
25. Bacon AS, Frazer DG, Dart JK, Matheson M, Ficker LA, Wright P. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye 1993, 7:719-25.
26. Butler TKH, Males JJ, Robinson LP. Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 1997-2002. Clin Experiment Ophthalmol 2005, 33:41-6.
27. McClellan K, Howard K, Niederkorn JY, Alizadeh H. Effect of steroids on Acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci 2001, 42:2885-93.
28. Winchester K, Mathers WD, Sutphin JE, Daley TE. Diagnosis of Acanthamoeba keratitis in vivo with confocal microscopy. Cornea 1995, 14:10-7.